These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 11509874)
1. Studies of hepatitis C virus in chimpanzees and their importance for vaccine development. Bukh J; Forns X; Emerson SU; Purcell RH Intervirology; 2001; 44(2-3):132-42. PubMed ID: 11509874 [TBL] [Abstract][Full Text] [Related]
2. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458 [TBL] [Abstract][Full Text] [Related]
3. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection. Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986 [TBL] [Abstract][Full Text] [Related]
4. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development. Alvarez-Lajonchere L; DueƱas-Carrera S Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022 [TBL] [Abstract][Full Text] [Related]
5. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Houghton M Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667 [TBL] [Abstract][Full Text] [Related]
6. Prospects for a vaccine against the hepatitis C virus. Houghton M; Abrignani S Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Vaccine Research: Time to Put Up or Shut Up. Hartlage AS; Kapoor A Viruses; 2021 Aug; 13(8):. PubMed ID: 34452460 [TBL] [Abstract][Full Text] [Related]
8. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy. Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891 [TBL] [Abstract][Full Text] [Related]
9. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees. Esumi M; Rikihisa T; Nishimura S; Goto J; Mizuno K; Zhou YH; Shikata T Arch Virol; 1999; 144(5):973-80. PubMed ID: 10416378 [TBL] [Abstract][Full Text] [Related]
10. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection. Puig M; Major ME; Mihalik K; Feinstone SM Vaccine; 2004 Feb; 22(8):991-1000. PubMed ID: 15161076 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C cross-genotype immunity and implications for vaccine development. Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Wong J; Tyndall MW; Janjua NZ; Sci Rep; 2017 Sep; 7(1):12326. PubMed ID: 28951612 [TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Rollier CS; Paranhos-Baccala G; Verschoor EJ; Verstrepen BE; Drexhage JA; Fagrouch Z; Berland JL; Komurian-Pradel F; Duverger B; Himoudi N; Staib C; Meyr M; Whelan M; Whelan JA; Adams VC; Larrea E; Riezu JI; Lasarte JJ; Bartosch B; Cosset FL; Spaan WJ; Diepolder HM; Pape GR; Sutter G; Inchauspe G; Heeney JL Hepatology; 2007 Mar; 45(3):602-13. PubMed ID: 17326154 [TBL] [Abstract][Full Text] [Related]
13. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus. Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702 [TBL] [Abstract][Full Text] [Related]
14. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses. Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021 [TBL] [Abstract][Full Text] [Related]
15. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371 [TBL] [Abstract][Full Text] [Related]
16. A critical role for the chimpanzee model in the study of hepatitis C. Bukh J Hepatology; 2004 Jun; 39(6):1469-75. PubMed ID: 15185284 [TBL] [Abstract][Full Text] [Related]
17. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537 [TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Farci P; Alter HJ; Wong DC; Miller RH; Govindarajan S; Engle R; Shapiro M; Purcell RH Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7792-6. PubMed ID: 7519785 [TBL] [Abstract][Full Text] [Related]
19. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins. Dahari H; Feinstone SM; Major ME Gastroenterology; 2010 Sep; 139(3):965-74. PubMed ID: 20621699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]